Showing results (331-340 of 10,059) with videos related to
Sort By:
Pageof 1,006
Current Pharmaceutical Design|November 17, 2004
Structural bioinformatic approaches to the discovery of new antimycobacterial drugsKatherine Kantardjieff, Bernhard RuppCurrent Pharmaceutical Design|February 23, 2005
Recent developments in the design of specific Matrix Metalloproteinase inhibitors aided by structural and computational studiesB Govinda RaoCurrent Pharmaceutical Design|February 23, 2005
Neurotransmitters and chemokines regulate tumor cell migration: potential for a new pharmacological approach to inhibit invasion and metastasis developmentFrank Entschladen, Theodore L Drell, Kerstin Lang, et al.Current Pharmaceutical Design|July 29, 2004
A(1) adenosine receptor agonists: medicinal chemistry and therapeutic potentialS A Hutchinson, P J ScammellsCurrent Pharmaceutical Design|July 29, 2004
Treatment of chronic hepatitis B: from research to clinical practice via the consensus conferencesM R Brunetto, F BoninoCurrent Pharmaceutical Design|July 29, 2004
A review of depsipeptide and other histone deacetylase inhibitors in clinical trialsRichard Piekarz, Susan BatesCurrent Pharmaceutical Design|July 29, 2004
Small molecule toxins targeting tumor receptorsMarcin Dyba, Nadya I Tarasova, Christopher J MichejdaCurrent Pharmaceutical Design|July 29, 2004
An expanding appreciation of the role chemokine receptors play in cancer progressionO M Zack Howard, Carole L GalliganCurrent Pharmaceutical Design|April 14, 2004
Biochemical and pharmacologic heterogeneity in low molecular weight heparins. Impact on the therapeutic profileJawed Fareed, Debra Hoppensteadt, Christopher Schultz, et al.Pageof 1,006